News

Filter

Current filters:

IndiaGlaxoSmithKline

GlaxoSmithKline’s $490 million fine to spark pharma strategy shift in emerging markets, says analyst

GlaxoSmithKline’s $490 million fine to spark pharma strategy shift in emerging markets, says analyst

25-09-2014

UK pharma giant GlaxoSmithKline’s involvement in a large-scale bribery scandal in China came to an…

BrazilChinaGlaxoSmithKlineIndiaManagementMarkets & MarketingPharmaceutical

Indian govt to penalize drugmakers for overcharging

Indian govt to penalize drugmakers for overcharging

06-05-2014

In a major crackdown, India's drug price regulator, the National Pharmaceutical Pricing Authority (NPPA)…

CiplaFinancialGlaxoSmithKlineIndiaPharmaceuticalPricing

GSK increases stake in Indian Pharma subsidiary to 75%

GSK increases stake in Indian Pharma subsidiary to 75%

10-03-2014

UK pharma giant GlaxoSmithKline says that, following the voluntary open offer undertaken by its Indian…

Asia-PacificGlaxoSmithKlineIndiaMergers & AcquisitionsPharmaceutical

India/USA trade dispute could impact AIDS treatment programs

10-03-2014

The trade dispute over intellectual property rights between the USA and India is set to derail the distribution…

Anti-viralsCiplaGenericsGilead SciencesGlaxoSmithKlineIndiaPatentsPricingUSA

Pharma multinationals facing more pricing problems in India

Pharma multinationals facing more pricing problems in India

03-02-2014

Even as a battle royal appears to be brewing between India's drug price regulator, the National Pharma…

Asia-PacificAstraZenecaFinancialGlaxoSmithKlineIndiaNovartisPfizerPharmaceuticalPricing

GlaxoSmithKline to lift stake in Indian subsidiary to 75%

GlaxoSmithKline to lift stake in Indian subsidiary to 75%

16-12-2013

UK pharma major GlaxoSmithKline said this morning that it plans to increase its stake in its publicly-listed…

Asia-PacificGlaxoSmithKlineIndiaMergers & AcquisitionsPharmaceutical

COMPANY SPOTLIGHT

Menarini

Back to top